ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,230Medicare Part D Prescriptions Filled, Including Refills

Rank: 206 out of 3734

$801K Total Retail Price of All Prescriptions

Rank: 215 out of 3734

707 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 707 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

7% of this provider’s 707 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

0% of this provider’s 12,405 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
SIMVASTATIN 491 424 1 1
LISINOPRIL 490 442 2 3
OMEPRAZOLE 475 404 3 4
LEVOTHYROXINE SODIUM 460 418 4 2
METOPROLOL SUCCINATE 405 388 5 14
AMLODIPINE BESYLATE 397 391 6 5
PRAVASTATIN SODIUM 354 328 7 15
LOSARTAN POTASSIUM 298 290 8 21
LOVASTATIN 286 243 9 41
FUROSEMIDE 263 257 10 7
ZOLPIDEM TARTRATE 255 223 11 24
ATORVASTATIN CALCIUM 223 201 12 11
HYDROCHLOROTHIAZIDE 215 193 13 9
LOSARTAN-HYDROCHLOROTHIAZIDE 205 197 14 71
CARVEDILOL 193 175 15 30
METOPROLOL TARTRATE 192 188 16 6
AMLODIPINE BESYLATE-BENAZEPRIL 190 169 17 56
ALENDRONATE SODIUM 186 182 18 26
METFORMIN HCL 179 162 19 8
SPIRIVA 178 142 20 40
PANTOPRAZOLE SODIUM 174 161 21 22
HYDROCODONE-ACETAMINOPHEN 168 143 S3 22 12
WARFARIN SODIUM 164 164 23 10
TRAMADOL HCL 150 124 24 20
GABAPENTIN 146 124 25 17
CITALOPRAM HBR 139 102 26 16
SERTRALINE HCL 128 105 27 18
MIRTAZAPINE 128 117 27 45
ATENOLOL 127 115 29 13
CRESTOR 121 120 30 28
DILTIAZEM 24HR CD 120 113 31 97
LISINOPRIL-HYDROCHLOROTHIAZIDE 118 93 32 27
NEXIUM 116 82 33 36
METFORMIN HCL ER 113 105 34 66
OXYCODONE-ACETAMINOPHEN 106 83 S2 35 51
CLOPIDOGREL 104 102 36 23
DIOVAN 103 101 37 31
FENTANYL 102 84 S2 38 65
BUPROPION XL 96 70 39 250
DILTIAZEM 24HR ER 94 94 40 86
DIGOXIN 93 84 41 43
ALLOPURINOL 85 82 42 33
OLANZAPINE 84 83 43 106
BENAZEPRIL HCL 79 75 44 103
TAMSULOSIN HCL 76 71 45 29
ADVAIR DISKUS 75 63 46 35
VENTOLIN HFA 75 58 46 70
ENDOCET 73 13 S2 48 89
GLIMEPIRIDE 72 72 49 37
AZITHROMYCIN 72 59 49 38
BUMETANIDE 71 57 51 78
JANUVIA 70 70 52 50
VESICARE 69 69 53 157
FLUTICASONE PROPIONATE 69 43 53 46
QUETIAPINE FUMARATE 65 49 55 82
ESCITALOPRAM OXALATE 65 63 55 68
EVISTA 64 55 57 130
PROPRANOLOL HCL 63 56 58 126
GLIPIZIDE 62 60 59 57
FENOFIBRATE 60 45 60 81
SPIRONOLACTONE 59 53 61 80
BUPROPION HCL SR 57 41 62 165
PLAVIX 57 52 62 39
PAROXETINE HCL 56 33 64 59
ATELVIA 55 55 65 264
LACTULOSE 53 0 66 137
TRAZODONE HCL 53 26 66 49
COREG CR 52 52 68 334
ENALAPRIL MALEATE 51 45 69 63
ISOSORBIDE MONONITRATE ER 50 50 70 34
SINGULAIR 50 43 70 95
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 24, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.